id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zvcybNU-EemFbq_Ii70mgg,jgraPEon,https://europepmc.org/articles/PMC4452330/,extrahepatic primary tumor,t [36]. A search to rule out an , should therefore usually be per,TextQuoteSelector,TextPositionSelector,16791,16817,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:22:14.559347+00:00
zsYr9tU8Eem_tDfCGHIGdw,jgraPEon,https://europepmc.org/articles/PMC4452330/,hepatitis C virus infection ,by Shaib et al. that noted that ,was significantly more prevalent,TextQuoteSelector,TextPositionSelector,12597,12625,"WT_OG,DS",no,[WT_OG][DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:07:55.364991+00:00
zg7_oNU6EemcGJNWfORuWA,jgraPEon,https://europepmc.org/articles/PMC4452330/,Opisthorchis viverrini,ion with Clonorchis sinensis or ,", inflammatory bowel disease, an",TextQuoteSelector,TextPositionSelector,10671,10693,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:53:35.034930+00:00
zaBenNVJEemeJgsCl-1Mng,jgraPEon,https://europepmc.org/articles/PMC4452330/,localized disease, that only 37% of patients with , underwent cancer directed surge,TextQuoteSelector,TextPositionSelector,26685,26702,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:40:56.769067+00:00
yt6tPNVMEemvRZ8E_ET2lw,jgraPEon,https://europepmc.org/articles/PMC4452330/,VEGF,ular endothelial growth factor (,") pathway, involved in angiogene",TextQuoteSelector,TextPositionSelector,35830,35834,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:02:20.750344+00:00
yTjlTNU9EemDoqv76uyWbw,jgraPEon,https://europepmc.org/articles/PMC4452330/,jaundice,"bdominal pain, night sweats, or ","; however, the frequent biliary ",TextQuoteSelector,TextPositionSelector,15262,15270,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:14:55.389132+00:00
xzq7RNVMEem8NxvortTpWg,jgraPEon,https://europepmc.org/articles/PMC4452330/,vascular endothelial growth factor,langiocarcinoma. Targets of the ," (VEGF) pathway, involved in ang",TextQuoteSelector,TextPositionSelector,35794,35828,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:02:14.267107+00:00
xyW-bNVKEemy4nOGGDmeyw,jgraPEon,https://europepmc.org/articles/PMC4452330/,solitary tumors,tion is defined as follows: T1: ," without vascular invasion, T2: ",TextQuoteSelector,TextPositionSelector,23362,23377,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:47:55.493897+00:00
wgIDXNU5Eemakpd7ps-sQw,jgraPEon,https://europepmc.org/articles/PMC4452330/,parasitic biliary infection,"sts, primary biliary cirrhosis, ", with Clonorchis sinensis or Opi,TextQuoteSelector,TextPositionSelector,10615,10642,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:46:05.409660+00:00
vc9gTtU6EemFiNcM9Q4YLg,jgraPEon,https://europepmc.org/articles/PMC4452330/,Clonorchis sinensis,arasitic biliary infection with ," or Opisthorchis viverrini, infl",TextQuoteSelector,TextPositionSelector,10648,10667,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:53:07.867841+00:00
vOQKKtU8EemiTjdguEBBxQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,hepatitis C,fatty liver disease (NAFLD) and ,. The association between ICC an,TextQuoteSelector,TextPositionSelector,12454,12465,"WT_OG,DS",yes,[WT_OG][DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:07:25.172098+00:00
v3gRNtVMEemiW3dMmIJSTQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,oncogenesis,isms and mutations critical for , in cholangiocarcinoma. Targets ,TextQuoteSelector,TextPositionSelector,35744,35755,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:02:01.493827+00:00
uegWfNVGEem4Xas7U1YnUA,jgraPEon,https://europepmc.org/articles/PMC4452330/,alpha-fetoprotein,"Carcinoembryonic antigen (CEA), "," (AFP), and carbohydrate antigen",TextQuoteSelector,TextPositionSelector,17232,17249,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:18:55.045743+00:00
uUFaONU5EemDn-_2f-mrEg,jgraPEon,https://europepmc.org/articles/PMC4452330/,primary biliary cirrhosis,"tolithiasis, choledochal cysts, ",", parasitic biliary infection wi",TextQuoteSelector,TextPositionSelector,10588,10613,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:45:50.272693+00:00
txq2uNU6EemOTHO7Cp8FLg,jgraPEon,https://europepmc.org/articles/PMC4452330/,Clonorchis sinensis,"factorsCongenital risk factors 
"," 
 Caroli's disease 
Opisthorchi",TextQuoteSelector,TextPositionSelector,12010,12029,MIS_OG,no,MIS_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:52:56.616417+00:00
taheMNVNEem1ccvvHn0Uww,jgraPEon,https://europepmc.org/articles/PMC4452330/,resp,"nly (47% versus 20% versus 33%, ",".; P = 0.03) [119]. However, thi",TextQuoteSelector,TextPositionSelector,43757,43761,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:08:54.644849+00:00
sywYONU8EemvOPv1u9_SJQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,nonalcoholic fatty liver disease,ased in incidence worldwide are , (NAFLD) and hepatitis C. The as,TextQuoteSelector,TextPositionSelector,12409,12441,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:07:08.797827+00:00
shwE2NU5Eem-byPBT-nMVQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,choledochal cysts,"g cholangitis, hepatolithiasis, ",", primary biliary cirrhosis, par",TextQuoteSelector,TextPositionSelector,10569,10586,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:45:38.738676+00:00
s7lQxNVJEemlaktA8YgwWA,jgraPEon,https://europepmc.org/articles/PMC4452330/,liver metastases,neal carcinomatosis (11/14) and , (5/14) in a small subset of pat,TextQuoteSelector,TextPositionSelector,26059,26075,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:40:13.425812+00:00
rwR3jNVGEem1b6dcgfnbvQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,Carcinoembryonic antigen, should be assessed (Figure 1). ," (CEA), alpha-fetoprotein (AFP),",TextQuoteSelector,TextPositionSelector,17200,17224,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:18:37.028000+00:00
rLxDmtU5Eemhfm-kG0CrvQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,hepatolithiasis,"primary sclerosing cholangitis, ",", choledochal cysts, primary bil",TextQuoteSelector,TextPositionSelector,10552,10567,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:45:29.663363+00:00
rFJjPtVJEemvRAN0Tx8EFw,jgraPEon,https://europepmc.org/articles/PMC4452330/,peritoneal carcinomatosis, staging laparoscopy identified , (11/14) and liver metastases (5,TextQuoteSelector,TextPositionSelector,26021,26046,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:40:01.004008+00:00
pu00iNU5EempBcvmOlq3Gg,jgraPEon,https://europepmc.org/articles/PMC4452330/,primary sclerosing cholangitis,eral other risk factors include ,", hepatolithiasis, choledochal c",TextQuoteSelector,TextPositionSelector,10520,10550,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:45:19.871606+00:00
paB51tUmEem4QA_tHAbPMw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Cholangiocarcinoma,f all gastrointestinal cancers. , can be classified into intrahep,TextQuoteSelector,TextPositionSelector,7339,7357,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:29:17.380839+00:00
pSNd2tVNEemQYJe8o2O9FQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,hilar cholangiocarcinoma, transplant for intrahepatic or ,. The 5-year tumor recurrence-fr,TextQuoteSelector,TextPositionSelector,43407,43431,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:08:26.833057+00:00
pIlAFtU9EemQXUOcvKwjIA,jgraPEon,https://europepmc.org/articles/PMC4452330/,biliary obstruction,istal ducts often presents with ,", ICC is often an incidental rad",TextQuoteSelector,TextPositionSelector,14994,15013,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:13:53.871955+00:00
oEKxhNVJEemHmr9X60lGOQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,abdominal tumors,"cations, similar to other solid ",", are included with N1 disease c",TextQuoteSelector,TextPositionSelector,23714,23730,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:39:40.647532+00:00
myyCfNU8EemjZq_8h12J4w,jgraPEon,https://europepmc.org/articles/PMC4452330/,Biliary cirrhosis,o use Hepatolithiasis  Age > 65 , Type II diabetes Inflammatory b,TextQuoteSelector,TextPositionSelector,11843,11860,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:06:28.407990+00:00
mJUl2tU-EemlYYO5OJXB2Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,PSA,", BRST-2, AFP, CEA, CA19-9, and ",", may help to exclude common pri",TextQuoteSelector,TextPositionSelector,16273,16276,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:20:43.433244+00:00
mJ8actVIEemQB3-XPI8l4g,jgraPEon,https://europepmc.org/articles/PMC4452330/,multiple tumors," presence of vascular invasion, ",", symptomatic disease, and regio",TextQuoteSelector,TextPositionSelector,20899,20914,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:32:18.328900+00:00
m742_NVNEemkzVeDZmmSFg,jgraPEon,https://europepmc.org/articles/PMC4452330/,intraductal tumor,ary tumorTis Carcinoma in situ (,)T1 Solitary tumor without vascu,TextQuoteSelector,TextPositionSelector,24147,24164,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:08:11.037980+00:00
lVt6MNVJEemI43unUvtIiw,jgraPEon,https://europepmc.org/articles/PMC4452330/,T4,"nvasion of adjacent organs, and ",: tumors with any periductal-inf,TextQuoteSelector,TextPositionSelector,23590,23592,WT_OG,yes,[WT_OG][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:39:22.427024+00:00
lBzx8tU7EemvLoflqOobeg,jgraPEon,https://europepmc.org/articles/PMC4452330/,tobacco,"s B infection [15, 17, 18], and ", use [14] have been implicated i,TextQuoteSelector,TextPositionSelector,11074,11081,WT_OG,no,[WT_OG],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:59:07.443530+00:00
kyEvsNU8Eem0QLeFGh98tw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Hepatolithiasis,erosing cholangitis Tobacco use ,  Age > 65 Biliary cirrhosis Typ,TextQuoteSelector,TextPositionSelector,11817,11832,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:06:15.187444+00:00
kF_XJNVOEem2cv86jdl33Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,regional lymph node metastasis,"umors, symptomatic disease, and ", all to be associated with a wor,TextQuoteSelector,TextPositionSelector,20941,20971,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:15:01.567275+00:00
jzhArNUmEem0K_MLPYe26Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,gastrointestinal cancers,0 years and comprises 3% of all ,. Cholangiocarcinoma can be clas,TextQuoteSelector,TextPositionSelector,7313,7337,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:28:39.595354+00:00
jvumjNU7EemyPhfGFYwQVw,jgraPEon,https://europepmc.org/articles/PMC4452330/,hepatitis B infection,", diabetes [14, 16], cirrhosis, "," [15, 17, 18], and tobacco use [",TextQuoteSelector,TextPositionSelector,11034,11055,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:58:58.709287+00:00
jXUzfNU8Eem1YwtIlnS5Pg,jgraPEon,https://europepmc.org/articles/PMC4452330/,Primary sclerosing cholangitis,flammatory risk factors Obesity , Tobacco use Hepatolithiasis  Ag,TextQuoteSelector,TextPositionSelector,11774,11804,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:06:05.544217+00:00
iyFiktVNEem8OBMn_AT3kw,jgraPEon,https://europepmc.org/articles/PMC4452330/,perihilar cholangiocarcinoma, The role of transplantation in , is significantly more defined; ,TextQuoteSelector,TextPositionSelector,42986,43014,WS_DS,yes,[WS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:07:43.209035+00:00
hztlLtU-EemQYBfMJpi25Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,CEA,"-2, TTF-1, ER, PR, BRST-2, AFP, ",", CA19-9, and PSA, may help to e",TextQuoteSelector,TextPositionSelector,16256,16259,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:20:13.791121+00:00
ht4v5NU-EemvPYO5E7giHw,jgraPEon,https://europepmc.org/articles/PMC4452330/,AFP,", CDX-2, TTF-1, ER, PR, BRST-2, ",", CEA, CA19-9, and PSA, may help",TextQuoteSelector,TextPositionSelector,16251,16254,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:20:13.531891+00:00
hmRxGNU-EemhjOP7XAtuFw,jgraPEon,https://europepmc.org/articles/PMC4452330/,BRST-2,"K7, CK20, CDX-2, TTF-1, ER, PR, ",", AFP, CEA, CA19-9, and PSA, may",TextQuoteSelector,TextPositionSelector,16243,16249,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:20:12.777632+00:00
hQq7ztU5EemayefuGF8RWQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,hepatocellular carcinoma, primary liver malignancy after , with a varying incidence worldw,TextQuoteSelector,TextPositionSelector,8649,8673,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:44:23.044006+00:00
h2bedNUmEemxU3-o8AgS7A,jgraPEon,https://europepmc.org/articles/PMC4452330/,malignancy,helium. While being an uncommon , with an annual incidence in the,TextQuoteSelector,TextPositionSelector,7156,7166,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:28:26.579794+00:00
h0gBVtVKEemm-y8lQFRNqQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,lymph node metastases,ts with solitary tumors without ," was only 47%, while recurrence ",TextQuoteSelector,TextPositionSelector,31324,31345,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:46:08.222280+00:00
gmWkANUmEemxUqMKklV3hA,jgraPEon,https://europepmc.org/articles/PMC4452330/,malignant transformation,he bile ducts which arises from , of bile duct epithelium. While ,TextQuoteSelector,TextPositionSelector,7082,7106,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:28:18.252574+00:00
gVDtdNU9EemDobv_TVR30A,jgraPEon,https://europepmc.org/articles/PMC4452330/,failure to thrive,"tomegaly, malaise, weight loss, ",", abdominal pain, night sweats, ",TextQuoteSelector,TextPositionSelector,15210,15227,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:12:54.757709+00:00
g9IxkNU7EemPUCODtr74yg,jgraPEon,https://europepmc.org/articles/PMC4452330/,cirrhosis,"besity [15], diabetes [14, 16], ",", hepatitis B infection [15, 17,",TextQuoteSelector,TextPositionSelector,11023,11032,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:58:39.934600+00:00
fzftGNU8EemiTPveYSMmBw,jgraPEon,https://europepmc.org/articles/PMC4452330/,HIV,aceptives Hepatitis C Isoniazid , Asbestos RadonOpen in a separat,TextQuoteSelector,TextPositionSelector,12302,12305,MIS_OG,no,MIS_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:05:41.657772+00:00
ftQFvNVNEem2cFPaB4mLvQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,solid tumors,response evaluation criteria in ," (mRECIST), intra-arterial thera",TextQuoteSelector,TextPositionSelector,41765,41777,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:07:22.595530+00:00
fJoU6NUmEem2TC-z-czFAg,jgraPEon,https://europepmc.org/articles/PMC4452330/,cancer of the bile ducts,inoma is a highly fatal primary , which arises from malignant tra,TextQuoteSelector,TextPositionSelector,7039,7063,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:28:08.296274+00:00
ejV9ENVNEem3vH9fqjI33g,jgraPEon,https://europepmc.org/articles/PMC4452330/,early necrosis,nical effectiveness measured by , was seen in 90–100% of small tu,TextQuoteSelector,TextPositionSelector,42594,42608,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:07:14.789266+00:00
ei91MtU5EemcFfsMpJSm0g,jgraPEon,https://europepmc.org/articles/PMC4452330/,primary liver cancers,yICC accounts for 10–15% of all , worldwide and is the second mos,TextQuoteSelector,TextPositionSelector,8556,8577,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:44:04.473365+00:00
dH7DOtUmEemOPDtT9q3GOQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,Cholangiocarcinoma,r articles in PMC.Go to:Abstract, is a highly fatal primary cance,TextQuoteSelector,TextPositionSelector,6994,7012,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:27:54.802448+00:00
cnaqSNU7Eem8JPd4iabDUg,jgraPEon,https://europepmc.org/articles/PMC4452330/,diabetes,"ver disease [14], obesity [15], "," [14, 16], cirrhosis, hepatitis ",TextQuoteSelector,TextPositionSelector,11004,11012,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:58:10.889515+00:00
c_k14tU8EemQW_eQFjvJDA,jgraPEon,https://europepmc.org/articles/PMC4452330/,Hepatitis C,Hepatitis B Oral contraceptives , Isoniazid HIV Asbestos RadonOpe,TextQuoteSelector,TextPositionSelector,12280,12291,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:05:22.919960+00:00
cAX9TtU8Eem1YldVv5Sglw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Hepatitis B,otrastViral risk factors Dioxin , Oral contraceptives Hepatitis C,TextQuoteSelector,TextPositionSelector,12248,12259,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:05:16.386953+00:00
byLJBNVJEemZ2t8SbZ63AQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,tumors,ation is based on the number of ,", vascular invasion, and direct ",TextQuoteSelector,TextPositionSelector,23238,23244,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:38:18.240460+00:00
boWRsNVKEemvRHdDhgMm3A,jgraPEon,https://europepmc.org/articles/PMC4452330/,nodal,studies have noted that overall ," status (N0 versus N1), as well ",TextQuoteSelector,TextPositionSelector,29136,29141,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:45:26.780034+00:00
aqf2JNUmEemSyYelR0PE-w,jgraPEon,https://europepmc.org/articles/PMC4452330/,Intrahepatic Cholangiocarcinoma,ciplinary Care of Patients with ,: Updates in ManagementKelly J. ,TextQuoteSelector,TextPositionSelector,5197,5228,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T06:27:38.280317+00:00
_xSLiNU6EemOTTNxttwFuQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,inflammatory bowel disease,"nsis or Opisthorchis viverrini, ",", and chronic pancreatitis [14],",TextQuoteSelector,TextPositionSelector,10695,10721,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:54:57.363303+00:00
_q1_RNVMEemOYgNeKsVEcA,jgraPEon,https://europepmc.org/articles/PMC4452330/,epidermal growth factor,", involved in angiogenesis, and "," (EGF) pathway, involved in cell",TextQuoteSelector,TextPositionSelector,35875,35898,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:03:47.631208+00:00
_WWPKtVKEemc5it0cBrvSw,jgraPEon,https://europepmc.org/articles/PMC4452330/,biliary tract cancers,reatic (53 patients) as well as ," (37 patients), 5-FU, leucovorin",TextQuoteSelector,TextPositionSelector,33278,33299,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:49:26.519199+00:00
_NL2zNU9Eem0Q8uZA_LQzQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,adenocarcinoma,subsequent pathology revealing “,.” Due to the fact that most ade,TextQuoteSelector,TextPositionSelector,15950,15964,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:16:22.049994+00:00
_9Kv4tVIEem1cEff_-E36A,jgraPEon,https://europepmc.org/articles/PMC4452330/,Multiple tumors,tumor with vascular invasionT2b ,", with or without vascular invas",TextQuoteSelector,TextPositionSelector,24253,24268,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:35:11.586634+00:00
ZuXuBNU8Eem0P8eKFqGLAw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Biliary papillomatosis,le duct adenomas Vinyl chloride , ThorotrastViral risk factors Di,TextQuoteSelector,TextPositionSelector,12189,12211,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:05:01.087692+00:00
YZEs8tU8EemOUres-0ZHQw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Bile duct adenomas,l hepatic fibrosis Nitrosamines , Vinyl chloride Biliary papillom,TextQuoteSelector,TextPositionSelector,12155,12173,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:04:52.081789+00:00
XH6tgtU-EemanTsFC3ZlYw,jgraPEon,https://europepmc.org/articles/PMC4452330/,PR,"ng CK7, CK20, CDX-2, TTF-1, ER, ",", BRST-2, AFP, CEA, CA19-9, and ",TextQuoteSelector,TextPositionSelector,16239,16241,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:19:02.574203+00:00
WcMaQtU-EemxZsNomg5_Ww,jgraPEon,https://europepmc.org/articles/PMC4452330/,ER,"luding CK7, CK20, CDX-2, TTF-1, ",", PR, BRST-2, AFP, CEA, CA19-9, ",TextQuoteSelector,TextPositionSelector,16235,16237,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:18:58.024639+00:00
Wbd6mtU8Eemkw-OQmDIUAQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,Congenital hepatic fibrosis,chal cystsChemical risk factors , Nitrosamines Bile duct adenomas,TextQuoteSelector,TextPositionSelector,12114,12141,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:04:38.867334+00:00
UcnZ_NU-EemlX6dLmI8ojQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,TTF-1,"rs, including CK7, CK20, CDX-2, ",", ER, PR, BRST-2, AFP, CEA, CA19",TextQuoteSelector,TextPositionSelector,16228,16233,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:18:44.653495+00:00
Tudf_tU8EemamMNkpgJ_-g,jgraPEon,https://europepmc.org/articles/PMC4452330/,Choledochal cysts,"sease 
Opisthorchis viverrini 
 ",Chemical risk factors Congenital,TextQuoteSelector,TextPositionSelector,12075,12092,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:04:20.794581+00:00
S1ExxNU-EemcHk_pmhJqlg,jgraPEon,https://europepmc.org/articles/PMC4452330/,CDX-2,"l markers, including CK7, CK20, ",", TTF-1, ER, PR, BRST-2, AFP, CE",TextQuoteSelector,TextPositionSelector,16221,16226,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:18:33.650280+00:00
RyEOZtVOEemZ3b_8SMZd5g,jgraPEon,https://europepmc.org/articles/PMC4452330/,ICCs,"ung, breast, and prostate [29]. "," are often positive for CK7, CEA",TextQuoteSelector,TextPositionSelector,16369,16373,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:12:58.594020+00:00
Rnhr9tU8EemFirs_0oSYsA,jgraPEon,https://europepmc.org/articles/PMC4452330/,Caroli's disease," factors 
Clonorchis sinensis 
 "," 
Opisthorchis viverrini 
 Chole",TextQuoteSelector,TextPositionSelector,12032,12048,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:04:06.552419+00:00
RKcBXtVTEemHnBNI99dPxQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,cancer,ith localized disease underwent , directed surgery [54]. While th,TextQuoteSelector,TextPositionSelector,26713,26719,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:48:41.912231+00:00
QqxRINU-Eem6BveWhwWwjg,jgraPEon,https://europepmc.org/articles/PMC4452330/,CK20,"hemical markers, including CK7, ",", CDX-2, TTF-1, ER, PR, BRST-2, ",TextQuoteSelector,TextPositionSelector,16215,16219,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:18:19.161932+00:00
QhQ5xNU7EemZyRvNCFlKTw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Obesity,actorsInflammatory risk factors , Primary sclerosing cholangitis ,TextQuoteSelector,TextPositionSelector,11766,11773,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:56:49.653579+00:00
PsKw7tVTEemFgHc15oYR1Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,Cancer,y from Memorial Sloan Kettering , Center noted that only 30% of p,TextQuoteSelector,TextPositionSelector,27383,27389,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:48:32.010757+00:00
PUSQ4tU7EemcGr-N4X0GCw,jgraPEon,https://europepmc.org/articles/PMC4452330/,obesity,"s alcoholic liver disease [14], "," [15], diabetes [14, 16], cirrho",TextQuoteSelector,TextPositionSelector,10990,10997,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:56:41.565608+00:00
PQ3tytVLEemy43e0R-ZeaQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,rare diseases,ing quality phase III trials in , such as cholangiocarcinoma. The,TextQuoteSelector,TextPositionSelector,35098,35111,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:51:13.323752+00:00
P3cBKtVJEemS4bO4ViHx5w,jgraPEon,https://europepmc.org/articles/PMC4452330/,Tumor, or without vascular invasionT3 , perforating the visceral perito,TextQuoteSelector,TextPositionSelector,24306,24311,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:36:58.264711+00:00
P0Wl5NVOEemMBT-ygAgnbQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,ICC,e classified into intrahepatic (,) and extrahepatic (including hi,TextQuoteSelector,TextPositionSelector,7395,7398,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:12:45.181747+00:00
OLCr0tU8Eem6ATcynYQiGw,jgraPEon,https://europepmc.org/articles/PMC4452330/,NAFLD,ake Biliary-enteric anastomosis ,Parasitic risk factorsCongenital,TextQuoteSelector,TextPositionSelector,11958,11963,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:03:43.256528+00:00
O3ycKtVIEem8MB-9dVer6Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,metastatic adenocarcinoma,"liably distinguish between ICC, ", from extrahepatic primaries or ,TextQuoteSelector,TextPositionSelector,20232,20257,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:29:42.087641+00:00
O3Rb8NU-EemFbYNQPbDj2w,jgraPEon,https://europepmc.org/articles/PMC4452330/,CK7,"istochemical markers, including ",", CK20, CDX-2, TTF-1, ER, PR, BR",TextQuoteSelector,TextPositionSelector,16210,16213,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:18:06.978654+00:00
NR0QQNU9EemlXI-ZzZI6sQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,alcohol induced cirrhosis,"cluding HBV, HCV, PSC, NASH, or "," [29]. As such, it is likely tha",TextQuoteSelector,TextPositionSelector,14772,14797,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:10:47.027418+00:00
NOX33tVTEem_wR9CtOh0ng,jgraPEon,https://europepmc.org/articles/PMC4452330/,Cancer,CC)/International Union Against , (UICC) guidelines that were pub,TextQuoteSelector,TextPositionSelector,20440,20446,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:48:15.590840+00:00
NKsN-tVIEem4XoMgWu3e1w,jgraPEon,https://europepmc.org/articles/PMC4452330/,tumors,ministration showed that 74% of , had hyperattenuating delayed co,TextQuoteSelector,TextPositionSelector,20091,20097,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:29:30.635982+00:00
MsJfmNU5Eem1WwtNDoU7UQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,chronic liver disease ,ormal liver and with underlying ,[3].Go to:2. EpidemiologyICC acc,TextQuoteSelector,TextPositionSelector,8478,8500,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:42:05.114316+00:00
MgX1xtVLEemQXmNNcTUrlA,jgraPEon,https://europepmc.org/articles/PMC4452330/,bile duct cancers,ile this study did not stratify ," by location, upon subgroup anal",TextQuoteSelector,TextPositionSelector,34649,34666,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:50:54.699377+00:00
MOuLWNVTEemwUCMPUwoJrw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Cancer,the American Joint Committee on , (AJCC)/International Union Agai,TextQuoteSelector,TextPositionSelector,20398,20404,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:48:08.915092+00:00
MGkzsNVJEemFeiulEQBl9Q,jgraPEon,https://europepmc.org/articles/PMC4452330/,Solitary tumor,a in situ (intraductal tumor)T1 , without vascular invasionT2a So,TextQuoteSelector,TextPositionSelector,24168,24182,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:36:32.938359+00:00
LFu_dtU7EemIbiPUS0FZGg,jgraPEon,https://europepmc.org/articles/PMC4452330/,HCC,s for hepatocellular carcinoma (,) such as alcoholic liver diseas,TextQuoteSelector,TextPositionSelector,10947,10950,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:56:13.363444+00:00
L8qExtU7Eem2aG8sPakzpg,jgraPEon,https://europepmc.org/articles/PMC4452330/,alcoholic liver disease,ellular carcinoma (HCC) such as ," [14], obesity [15], diabetes [1",TextQuoteSelector,TextPositionSelector,10960,10983,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:56:18.994889+00:00
KzCS_tU-EemeGwfYxgYJJw,jgraPEon,https://europepmc.org/articles/PMC4452330/,extrahepatic adenocarcinomas ,tatic lesions to the liver from ,of the foregut [36]. A search to,TextQuoteSelector,TextPositionSelector,16717,16746,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:17:39.699222+00:00
KrsjiNVOEem2eS8eHPJpUQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,Intrahepatic Bile Duct Tumors, Cancer (AJCC). TNM Staging for ," (7th edition, 2010).Primary tum",TextQuoteSelector,TextPositionSelector,23991,24020,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:12:10.922952+00:00
KoaOAtVJEemS4McL7O6img,jgraPEon,https://europepmc.org/articles/PMC4452330/,Carcinoma in situ,No evidence of primary tumorTis , (intraductal tumor)T1 Solitary ,TextQuoteSelector,TextPositionSelector,24128,24145,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:36:23.138428+00:00
KOTn8tVNEemhk89eyOkmhw,jgraPEon,https://europepmc.org/articles/PMC4452330/,platelet derived growth factor,"tocyte growth factor, BRAF, and ", hopefully will lead to effectiv,TextQuoteSelector,TextPositionSelector,36461,36491,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:04:58.404367+00:00
J2IVVNU9EemwQQcVJ-YpvQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,PSC,"isk factors including HBV, HCV, ",", NASH, or alcohol induced cirrh",TextQuoteSelector,TextPositionSelector,14758,14761,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:10:23.999942+00:00
I_LPhtU8EemlWLeh8rmECg,jgraPEon,https://europepmc.org/articles/PMC4452330/,Type II diabetes,sis  Age > 65 Biliary cirrhosis , Inflammatory bowel disease Exce,TextQuoteSelector,TextPositionSelector,11861,11877,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:03:08.732447+00:00
I3FnLtU9Eem4ULMbrJShmg,jgraPEon,https://europepmc.org/articles/PMC4452330/,HBV,he major risk factors including ,", HCV, PSC, NASH, or alcohol ind",TextQuoteSelector,TextPositionSelector,14748,14751,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:10:17.361653+00:00
H5VdvNVNEemFftvirT_TQw,jgraPEon,https://europepmc.org/articles/PMC4452330/,BRAF,"hway, hepatocyte growth factor, ",", and platelet derived growth fa",TextQuoteSelector,TextPositionSelector,36451,36455,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:04:42.728842+00:00
GjQliNU5EemHg1tZPrhyDQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,mouse, epithelium. Recent research in , models suggests the possibility,TextQuoteSelector,TextPositionSelector,7856,7861,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:41:23.799481+00:00
GAhrttVIEemQbbeb438sPA,jgraPEon,https://europepmc.org/articles/PMC4452330/,desmoplastic,"ation, a finding related to the ", nature of the tumor. In one stu,TextQuoteSelector,TextPositionSelector,19908,19920,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:28:42.610692+00:00
G8vL7tVNEempJ9fkVivB7g,jgraPEon,https://europepmc.org/articles/PMC4452330/,hepatocyte growth factor,"a including map kinase pathway, ",", BRAF, and platelet derived gro",TextQuoteSelector,TextPositionSelector,36425,36449,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:04:36.463986+00:00
Fhv4cNU7EemE2f8NaYxZ2g,jgraPEon,https://europepmc.org/articles/PMC4452330/,chronic pancreatitis,"inflammatory bowel disease, and "," [14], as well as the historical",TextQuoteSelector,TextPositionSelector,10727,10747,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:55:35.688198+00:00
FdTVqtVNEemFfZumGCYzrg,jgraPEon,https://europepmc.org/articles/PMC4452330/,map kinase,in cholangiocarcinoma including ," pathway, hepatocyte growth fact",TextQuoteSelector,TextPositionSelector,36405,36415,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:04:26.277971+00:00
DKTr8NU-Eem6BbMjlSl-Tw,jgraPEon,https://europepmc.org/articles/PMC4452330/,tumor, to elucidate the origin of the ,. Some immunohistochemical marke,TextQuoteSelector,TextPositionSelector,16159,16164,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:16:48.570025+00:00
DJHuuNU7Eem4TTMr0_AitA,jgraPEon,https://europepmc.org/articles/PMC4452330/,Inflammatory bowel disease,iary cirrhosis Type II diabetes , Excessive alcohol intake Biliar,TextQuoteSelector,TextPositionSelector,11878,11904,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:55:20.005763+00:00
DAbdqNVHEemyQDOPAVSGCg,jgraPEon,https://europepmc.org/articles/PMC4452330/,biglycan,"inding protein 5 (IGFBP-5), and "," exist; however, none of these a",TextQuoteSelector,TextPositionSelector,18151,18159,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:21:13.056877+00:00
D3YZDtU9Eem-dQvh5Hkazw,jgraPEon,https://europepmc.org/articles/PMC4452330/,NASH,o nonalcoholic steatohepatitis (,"), eventual cirrhosis, and HCC [",TextQuoteSelector,TextPositionSelector,13495,13499,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:09:43.879614+00:00
CrwCMtVOEemy5HtmIXoVKA,jgraPEon,https://europepmc.org/articles/PMC4452330/,Klatskin Tumors,n of hilar cholangiocarcinomas (,) on the incidence of intra- and,TextQuoteSelector,TextPositionSelector,48203,48218,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:11:17.372836+00:00
CXxoltU9EemvOlPx0vyTDQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,nonalcoholic steatohepatitis,nited States. NAFLD can lead to ," (NASH), eventual cirrhosis, and",TextQuoteSelector,TextPositionSelector,13465,13493,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:09:33.715926+00:00
BcVqWtVLEema2oOXGbc5WA,jgraPEon,https://europepmc.org/articles/PMC4452330/,biliary tract cancer,trial in patients with advanced , that compared single agent gemc,TextQuoteSelector,TextPositionSelector,33987,34007,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:49:40.438357+00:00
ArLuqNU-Eemm7P8FV0Sxkw,jgraPEon,https://europepmc.org/articles/PMC4452330/,adenocarcinomas,oma.” Due to the fact that most , of the liver are metastatic in ,TextQuoteSelector,TextPositionSelector,15993,16008,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:16:31.815885+00:00
ActIHtVNEemIf_eQ8kdHlQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,EGF,"s, and epidermal growth factor (",") pathway, involved in cell prol",TextQuoteSelector,TextPositionSelector,35900,35903,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:03:52.870332+00:00
9oeRjNVIEemQXJNT0pi6Vg,jgraPEon,https://europepmc.org/articles/PMC4452330/,Primary tumor,"Duct Tumors (7th edition, 2010).", (T)TX Primary tumor cannot be a,TextQuoteSelector,TextPositionSelector,24041,24054,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:34:55.854107+00:00
9epMZtU9Eemc3PNIISXTag,jgraPEon,https://europepmc.org/articles/PMC4452330/,metastatic disease,om hepatocellular carcinoma and ,. While there is a theoretical r,TextQuoteSelector,TextPositionSelector,15599,15617,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:16:10.497043+00:00
9JffUtVOEema3HN5cSAMOQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,lymph node metastasis,o underwent lymphadenectomy had ," [58]. Some investigators, howev",TextQuoteSelector,TextPositionSelector,28480,28501,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:17:49.569132+00:00
98Gs_NVKEemIfnfx_eK9pw,jgraPEon,https://europepmc.org/articles/PMC4452330/,malignancies,geneous nature of biliary tract ,". Historically, 5-FU was the fir",TextQuoteSelector,TextPositionSelector,33046,33058,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:49:17.051471+00:00
94-OYNVGEemFm3dHPBjKag,jgraPEon,https://europepmc.org/articles/PMC4452330/,IGFBP-5,rowth factor binding protein 5 (,"), and biglycan exist; however, ",TextQuoteSelector,TextPositionSelector,18137,18144,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:20:38.728498+00:00
8OpqlNVGEemFeNMkaYDVOA,jgraPEon,https://europepmc.org/articles/PMC4452330/,insulin-like growth factor binding protein 5,"s such as CYFRA21-1, claudin-4, "," (IGFBP-5), and biglycan exist; ",TextQuoteSelector,TextPositionSelector,18091,18135,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:20:27.493557+00:00
7r5TutU9EemvNkfz7-SEPQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,cholangiocarcinomas,ration (EUS-FNA) to distinguish , from hepatocellular carcinoma a,TextQuoteSelector,TextPositionSelector,15545,15564,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:15:58.361024+00:00
5Ykl9NVHEemOX9-5T1AZGw,jgraPEon,https://europepmc.org/articles/PMC4452330/,intrahepatic cholangiocarcinoma,Figure 1Treatment algorithm for ,.4.1. ICC on Cross-Sectional Ima,TextQuoteSelector,TextPositionSelector,18286,18317,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:27:17.958343+00:00
552L2NVGEemIe9MZYwW9ig,jgraPEon,https://europepmc.org/articles/PMC4452330/,claudin-4," serum marks such as CYFRA21-1, ",", insulin-like growth factor bin",TextQuoteSelector,TextPositionSelector,18080,18089,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:20:11.974743+00:00
4o6dBNVKEem8Mmvr-93rtw,jgraPEon,https://europepmc.org/articles/PMC4452330/,Biliary Cancer," and ECC. In 2010, the Advanced ",- (ABC-) 02 trial was published.,TextQuoteSelector,TextPositionSelector,33859,33873,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:48:41.375700+00:00
4fuoBNVGEemS34u1R9Os2w,jgraPEon,https://europepmc.org/articles/PMC4452330/,CYFRA21-1,re specific serum marks such as ,", claudin-4, insulin-like growth",TextQuoteSelector,TextPositionSelector,18069,18078,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:20:02.455181+00:00
43FP2NU6EemlVssAjb0GSA,jgraPEon,https://europepmc.org/articles/PMC4452330/,Opisthorchis viverrini,"is sinensis 
 Caroli's disease 
"," 
 Choledochal cystsChemical ris",TextQuoteSelector,TextPositionSelector,12050,12072,MIS_OG,no,MIS_OG,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T08:54:11.016808+00:00
2IoBJtVGEemFd3cVcjsQgQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,acute cholangitis,ed that biliary obstruction and , may also cause an increase in C,TextQuoteSelector,TextPositionSelector,17889,17906,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T10:19:46.591381+00:00
25hEkNU8Eemy1vPy6P-BQw,jgraPEon,https://europepmc.org/articles/PMC4452330/,HCV,) [23]. The association between , and ICC is not unique to the US,TextQuoteSelector,TextPositionSelector,12928,12931,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:08:16.839026+00:00
1IrrlNU8EemaztsAoAH0Ow,jgraPEon,https://europepmc.org/articles/PMC4452330/,HCV infection, risk for ICC in the setting of , (hazard ratio (HR): 2.55; 95% c,TextQuoteSelector,TextPositionSelector,12812,12825,"WT_OG,DS",no,[WT_OG][DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:08:04.950880+00:00
-t6zNtVOEemeK_vEdHSVRA,jgraPEon,https://europepmc.org/articles/PMC4452330/,metastatic nodal disease,"f these, 32% were found to have ", [50]. A second meta-analysis fr,TextQuoteSelector,TextPositionSelector,28265,28289,"WT_GP,DS",no,[WT_GP][DS],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T11:18:00.145204+00:00
-P--CNU-EemFkHOV7Zlz6A,jgraPEon,https://europepmc.org/articles/PMC4452330/,primary tumor,ntrathoracic or intra-abdominal , can also be helpful.In addition,TextQuoteSelector,TextPositionSelector,17055,17068,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:23:25.187365+00:00
--UR4tU8Eem3rAs04TdBWQ,jgraPEon,https://europepmc.org/articles/PMC4452330/,metabolic syndrome, is associated with obesity and ,", is an increasing concern world",TextQuoteSelector,TextPositionSelector,13355,13373,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.,2019-09-12T09:09:10.963877+00:00
